Sign in
4

Changes in Ownership

RenovoRx, Inc. Filed Acc 0001493152-24-003520

Options or other derivatives

  • Chief Medical Officer acquired 153,556 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Agah Ramtin Chief Medical Officer 2024-01-19 Grant or award · Stock Option +28,424 28,424 D
Agah Ramtin Chief Medical Officer 2024-01-19 Grant or award · Stock Option +125,132 125,132 D
Loading xslF345X05/ownership.xml…